Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disruption of mitochondrial complex I induces progressive parkinsonism
Patricia González‐Rodríguez, Enrico Zampese, Kristen A. Stout, et al.
Nature (2021) Vol. 599, Iss. 7886, pp. 650-656
Open Access | Times Cited: 391

Showing 26-50 of 391 citing articles:

In defence of ferroptosis
Francesca M. Alves, Darius J.R. Lane, Triet Phu Minh Nguyen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Type 2 Diabetes Mellitus Exacerbates Pathological Processes of Parkinson's Disease: Insights from Signaling Pathways Mediated by Insulin Receptors
Shufen Liu, Tingting Liu, Jingwen Li, et al.
Neuroscience Bulletin (2025)
Closed Access | Times Cited: 2
Pathogenesis of Parkinson’s Disease
Bin Xiao, Zhidong Zhou, Yinxia Chao, et al.
Neurologic Clinics (2025)
Closed Access | Times Cited: 2
Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies
Kai Meng, Hongyun Jia, Xiaoqing Hou, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 327-327
Open Access | Times Cited: 2
Synapses: The Brain’s Energy-Demanding Sites
Andreia Faria‐Pereira, Vanessa A. Morais
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3627-3627
Open Access | Times Cited: 69
Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges
Francesco Agostini, Anna Masato, Luigi Bubacco, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 398-398
Open Access | Times Cited: 63
Cardiac-specific overexpression of Ndufs1 ameliorates cardiac dysfunction after myocardial infarction by alleviating mitochondrial dysfunction and apoptosis
Bingchao Qi, Liqiang Song, Lang Hu, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 7, pp. 946-960
Open Access | Times Cited: 54
Antioxidant Supplementation in Oxidative Stress-Related Diseases: What Have We Learned from Studies on Alpha-Tocopherol?
Fleur L. Meulmeester, Jiao Luo, Leon G. Martens, et al.
Antioxidants (2022) Vol. 11, Iss. 12, pp. 2322-2322
Open Access | Times Cited: 51
Ca 2+ channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neurons
Enrico Zampese, David L. Wokosin, Patricia González‐Rodríguez, et al.
Science Advances (2022) Vol. 8, Iss. 39
Open Access | Times Cited: 49
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s
Christina E. Toomey, Wendy Heywood, James R. Evans, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 48
Striatal synaptic adaptations in Parkinson's disease
Weixing Shen, Shenyu Zhai, D. James Surmeier
Neurobiology of Disease (2022) Vol. 167, pp. 105686-105686
Open Access | Times Cited: 46
Mitolysosome exocytosis, a mitophagy-independent mitochondrial quality control in flunarizine-induced parkinsonism-like symptoms
Feixiang Bao, Lingyan Zhou, Rui Zhou, et al.
Science Advances (2022) Vol. 8, Iss. 15
Open Access | Times Cited: 44
Protein lifetimes in aged brains reveal a proteostatic adaptation linking physiological aging to neurodegeneration
Verena Kluever, Belisa Russo, Sunit Mandad, et al.
Science Advances (2022) Vol. 8, Iss. 20
Open Access | Times Cited: 44
Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson’s Disease
Ezia Guatteo, Nicola Berretta, Vincenzo Monda, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4508-4508
Open Access | Times Cited: 41
PARK7/DJ-1 promotes pyruvate dehydrogenase activity and maintains Treg homeostasis during ageing
Egle Danileviciute, Ni Zeng, Christophe Capelle, et al.
Nature Metabolism (2022) Vol. 4, Iss. 5, pp. 589-607
Open Access | Times Cited: 40
Irisin exhibits neuroprotection by preventing mitochondrial damage in Parkinson’s disease
Xi Zhang, Sutong Xu, Yong Hu, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 37
Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism
Pascale Baden, María José Pérez, Hariam Raji, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 36
Mitochondrial heterogeneity in diseases
Long Chen, Mengnan Zhou, Hao Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 35
The indirect pathway of the basal ganglia promotes transient punishment but not motor suppression
Brian Isett, Katrina P. Nguyen, Jenna C. Schwenk, et al.
Neuron (2023) Vol. 111, Iss. 14, pp. 2218-2231.e4
Open Access | Times Cited: 34
The Promise of Niacin in Neurology
Emily Wuerch, Gloria Roldan Urgoiti, V. Wee Yong
Neurotherapeutics (2023) Vol. 20, Iss. 4, pp. 1037-1054
Open Access | Times Cited: 32
Parkinson’s disease-linked parkin mutation disrupts recycling of synaptic vesicles in human dopaminergic neurons
Pingping Song, Wesley Peng, Véronique Sauvé, et al.
Neuron (2023) Vol. 111, Iss. 23, pp. 3775-3788.e7
Closed Access | Times Cited: 30
Mitochondrial Complex I as a Pathologic and Therapeutic Target for Parkinson’s Disease
Kamatham Pushpa Tryphena, Uppala Sai Nikhil, Poojitha Pinjala, et al.
ACS Chemical Neuroscience (2023)
Closed Access | Times Cited: 25
Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson’s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome
Wenlong Zhang, Shiyu Chen, Xingting Huang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 25
In vivoreduction of age-dependent neuromelanin accumulation mitigates features of Parkinson’s disease
Marta González-Sepúlveda, Joan Compte, Thaïs Cuadros, et al.
Brain (2023) Vol. 146, Iss. 3, pp. 1040-1052
Open Access | Times Cited: 23
Behavioral encoding across timescales by region-specific dopamine dynamics
Søren Jørgensen, Aske L. Ejdrup, Matthew D. Lycas, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 7
Open Access | Times Cited: 23

Scroll to top